Dilimulati Ismtula
Ueruemqi, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
The value of Protein Phosphatase Methylesterase 1 in diagnosis, prognosis and immunoregulation: from pan-cancer analysis to breast cancer verification.
Journal: Frontiers in immunology
Published: December 18, 2025
CORO1A: a pan-cancer prognosis, diagnostic and immune biomarker based on breast cancer validation.
Journal: Frontiers in oncology
Published: July 21, 2025
CLIC6's role in cancer: from broad analysis to breast cancer validation.
Journal: Frontiers in oncology
Published: July 16, 2025
Integrated Pan-Cancer Profiling and Breast Cancer Validation Identify BEND3 as a Potential Prognostic and Immune Biomarker.
Journal: Breast cancer (Dove Medical Press)
Published: July 14, 2025
Bystin is a Prognosis and Immune Biomarker: From Pan-Cancer Analysis to Validation in Breast Cancer.
Bystin is a Prognosis and Immune Biomarker: From Pan-Cancer Analysis to Validation in Breast Cancer.
Journal: Breast cancer (Dove Medical Press)
Published: June 11, 2025
Tubulin alpha-1b chain was identified as a prognosis and immune biomarker in pan-cancer combing with experimental validation in breast cancer.
Journal: Scientific reports
Published: January 18, 2024
Cytokine-induced apoptosis inhibitor 1: a comprehensive analysis of potential diagnostic, prognosis, and immune biomarkers in invasive breast cancer.
Journal: Translational cancer research
Published: January 07, 2023
Gelsolin: A comprehensive pan-cancer analysis of potential prognosis, diagnostic, and immune biomarkers.
Journal: Frontiers in genetics
Published: November 08, 2022
TIGIT as a Novel Prognostic Marker for Immune Infiltration in Invasive Breast Cancer.
Journal: Combinatorial chemistry & high throughput screening
Published: November 25, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026